# US 2026/0242815 A1 · Resistance gene to rhizomania

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0242815 A1
- Document ID: US20260242815A1
- Status: Published application
- Kind: A1
- Application number: 19/661,953
- Filed: 2026-04-29
- Published: 2026-08-20
- Earliest claimed: 2016-08-10
- Assignees: KWS SAAT SE & Co. KGaA
- Applicants: KWS SAAT SE & Co. KGaA
- Inventors: Ottó TÖRJÉK; Dietrich BORCHARDT; Wolfgang MECHELKE; Jens Christoph LEIN; Sandra HABEKOST
- Web page: https://patentgrep.com/patent/US20260242815A1

## CPC

- C12N 15/8279: {for biotic stress resistance, pathogen resistance, disease resistance}
- C07K 14/415: from plants
- C12N 15/8283: {for virus resistance}
- C12Q 1/6895: for plants, fungi or algae
- C12Q 2600/13: Plant traits
- C12Q 2600/156: Polymorphic or mutational markers
- Y02A 40/146: Genetically Modified [GMO] plants, e.g. transgenic plants
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- Y02A: TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE

## Abstract

The invention relates to nucleic acid molecules which impart resistance to rhizomania, in particular to Beet Necrotic Yellow Vein Virus (BNYVV) in a plant, in particular of the genus Beta, and to plants containing such nucleic acid molecules. The invention further relates to methods for producing such BNYVV resistant plants and to marker-based methods for identifying and selecting BNYVV resistant plants, as well as to methods for controlling infection with the pathogen BNYVV.

## Claims

### Claim 1

Nucleic acid molecule, which encodes a polypeptide that is capable of imparting a resistance to a pathogen in a plant in which the polypeptide is expressed, characterized in that the nucleic acid molecule comprises a nucleotide sequence selected from:
(a) a nucleotide sequence that encodes a polypeptide having an amino acid sequence as per SEQ ID NO: 2 or a polypeptide having an amino acid sequence that is at least 70% identical to SEQ ID NO: 2, in which at least one amino acid substitution is present as a result of one or more mutations of the nucleotide sequence, preferably, wherein lysine (K) at position 307 and/or glutamine (Q) at position 437 is substituted by another amino acid;
(b) a nucleotide sequence that comprises the sequence as per SEQ ID NO: 1 or that hybridizes with the complementary sequence to SEQ ID NO: 1 under stringent conditions, in which at least one nucleotide substitution is present as a result of one or more mutations, which leads to an amino acid substitution, preferably, wherein one or more nucleotides are substituted at positions 919-921 and/or at positions 1309-1311;
(c) a nucleotide sequence that encodes a polypeptide which, by substitution, deletion and/or addition from one or more amino acids of the amino acid sequence encoded by the nucleotide sequence according to (a) or (b), is derived from a polypeptide encoded by the nucleotide sequence according to (a) or (b), or
(d) a nucleotide sequence that encodes at least one leucine-rich domain (LRR) corresponding to
(i) the amino acid positions 558 to 594 of SEQ ID NO: 4, preferably the amino acid positions 542 to 594 of SEQ ID NO: 4,
(ii) the amino acid positions 604 to 634 of SEQ ID NO: 4, preferably the amino acid positions 582 to 634 of SEQ ID NO: 4,
(iii) the amino acid positions 760 to 790 of SEQ ID NO: 4 or
(iv) the amino acid positions 838 to 869 of SEQ ID NO: 4,
and/or at least one AAA ATPase domain corresponding to
(I) the amino acid positions 177 to 289 of SEQ ID NO: 4 or
(II) the amino acid positions 156 to 263 of SEQ ID NO: 4,
preferably wherein the pathogen is beet necrotic yellow vein virus (BNYVV) and the plant is a plant of the genus Beta, preferably sugar beet (Beta vulgaris L).

### Claim 2 (depends on 1)

Nucleic acid molecule according to claim 1, characterized in that the encoded polypeptide further comprises (i), at that position which in the reference amino acid sequence SEQ ID NO: 2 corresponds to position 566, an amino acid that differs from arginine (R), and/or (ii), at that position which in the reference amino acid sequence SEQ ID NO: 2 corresponds to position 731, an amino acid that differs from glutamine (Q), and/or (iii), at that position which in the reference amino acid sequence SEQ ID NO: 2 corresponds to position 831, an amino acid that differs from proline (P).

### Claim 3 (depends on 1, 2)

Nucleic acid molecule according to claim 1 or 2, characterized in that the encoded polypeptide (i) comprises a glutamine (Q) at that position which in the reference amino acid sequence SEQ ID NO: 2 corresponds to position 307, and/or (ii) comprises an arginine (R) at that position which in the reference amino acid sequence SEQ ID NO: 2 corresponds to position 437, and/or (iii) comprises a histidine (H) at that position which in the reference amino acid sequence SEQ ID NO: 2 corresponds to position 566, and/or (iv) comprises a lysine (K) at that position which in the reference amino acid sequence SEQ ID NO: 2 corresponds to position 731, and/or (v) comprises a serine(S) at that position which in the reference amino acid sequence SEQ ID NO: 2 corresponds to position 831.

### Claim 4 (depends on 3)

Nucleic acid molecule according to claim 3, characterized in that, at those locations which correspond to the locations in the reference nucleotide sequence SEQ ID NO: 1, the nucleic acid molecule comprises one or more of the following nucleotide substitutions:
(a) C instead of A at position 919;
(b) G instead of A at position 1310;
(c) A instead of G at position 1697;
(d) A instead of C at position 2191; and/or
(e) T instead of C at position 2491.

### Claim 5 (depends on 1, 2, 3, 4)

Nucleic acid molecule according to any one of claims 1 to 4, characterized in that the nucleic acid molecule encodes a polypeptide having an amino acid sequence as per SEQ ID NO: 4 and/or comprises the encoding DNA sequence as per SEQ ID NO: 3.

### Claim 6 (depends on 1, 2, 3, 4, 5)

Vector, which comprises the nucleic acid molecule according to any one of claims 1 to 5.

### Claim 7 (depends on 1, 2, 3, 4, 5, 6)

Transgenic plant cell, preferably from a plant of the genus Beta, which comprises the nucleic acid molecule according to any one of claims 1 to 5 as a transgene, optionally under the control of a heterologous promoter, or the vector according to claim 6.

### Claim 8 (depends on 7)

Transgenic plant, preferably of the genus Beta, or a part thereof, which comprises a plant cell according to claim 7.

### Claim 9 (depends on 1, 2, 3, 4, 5)

BNYVV-resistant plant of the genus Beta or a part thereof, in which the nucleic acid molecule according to any one of claims 1 to 5 is endogenously present, or in which the one or more mutations defined in any one of claims 1 to 4 have been introduced into an endogenous nucleic acid molecule having a nucleotide sequence that comprises the sequence as per SEQ ID NO: 1 or that hybridizes with the complementary sequence to SEQ ID NO: 1 under stringent conditions, wherein the plant or a part thereof does not belong to the subspecies Beta vulgaris subsp. maritima.

### Claim 10 (depends on 8, 9)

Plant according to claim 8 or 9, characterized in that the plant is a hybrid plant or a double-haploid plant and/or that the nucleic acid molecule or the one of the plurality of mutations is heterozygous or homozygous.

### Claim 11 (depends on 8, 9, 10)

Seed of the plant according to any one of claims 8 to 10, wherein the seed transgenically or endogenously comprises one or more of the aforementioned nucleic acid molecules or vectors.

### Claim 12 (depends on 1, 2, 3, 4, 5)

Method for producing a BNYVV-resistant plant, comprising the following steps:
(a) Mutagenizing of plant cells and subsequent regeneration of plants from the mutagenized plant cells or mutagenizing of plants, and optionally
(b) Identifying a plant from (a) which, in an endogenous nucleic acid molecule, comprises the one or more mutations defined in any one of claims 1 to 5.

### Claim 13 (depends on 1, 2, 3, 4, 5)

Method for identifying a plant of the genus Beta that is resistant to the pathogen BNYVV, characterized in that the method comprises the following step
(i) detecting the presence and/or expression of the nucleic acid molecule according to any one of claims 1 to 5 in the plant or in a sample thereof; and/or
(ii) detecting at least one marker locus in the nucleotide sequence of the nucleic acid molecule according to any one of claims 1 to 5 or the immediate vicinity, preferably on chromosome III, wherein the at least one marker locus preferably comprises the one or more mutations defined in any one of claims 1 to 4; and/or
(iii) detecting at least two marker loci on chromosome III in the plant, wherein at least one marker locus is located on or within the chromosomal interval from s3e4516s05 to the nucleic acid molecule according to any one of claims 1 to 5 and at least one marker locus is located on or within the chromosomal interval from the nucleic acid molecule according to any one of claims 1-4 to s3e5918s01; as well as optionally
(iv) selecting the BNYVV-resistant plant.

### Claim 14 (depends on 9, 10, 13)

Population of plants including plants according to any one of claim 9 or 10 or plants that have been identified and optionally selected using a method according to claim 13.

### Claim 15 (depends on 13)

Method for controlling infestation with the pathogen beet necrotic yellow vein virus (BNYVV) in the agricultural or horticultural cultivation of plants of the genus Beta, comprising
I) the identification and selection of plants of the genus Beta with the aid of a method according to claim 13 and
II) the cultivation of the plants from I) or the progeny thereof.
